"Khodairi" for new anti-cancer drug: will change treatment methods to 100%

He said: "Vitrakafi" targets the genetic origin and attack at the origin of the tumor .. completion

Professor Fahd Al-Khudairi, a professor and researcher in the field of carcinogens, confirmed that the new anti-cancer treatment discovered will change treatment methods by 100%.

He said, "Thank God, this is a new achievement and a new discovery for the treatment of cancer.This new drug aims at the genetic origin of cancer and treats the origin of the tumor and mutant genes before tumor spread.

The Food and Drug Administration (FDA) has announced the release of the first drug in the world to treat cancer of its origin and its origin, as well as for adults and children, said the commissioner of this organization.

Vitrakvi depends on the treatment of genetic mutations of cancerous tumors, regardless of the type or location of the disease, according to Sky News.

"The approval of the authorization and the introduction of this drug is an important step in the treatment of cancer, since it treats it from its source and treats the gene base of cancerous tumors independently from the location of their origin in the human body, "said Commissioner Scott Gottlieb.

Gottlieb has confirmed that the new drug will help cancer patients get proper treatment. Vitracave helps treat people with different cancers, but their genetic mutations are common.